Bezega M.I., Bezshapochnyy S.B., Loburets V.V., Loburets A.V., Bondarenko R.V., Bondarenko V.V., Dzhirov O.R.

LITERATURE REVIEWS

Scentific article

The article presents and considers common problems of etiology and pathogenesis of atrophic rhinitis and their consequences in our time. The issues of atrophy of the nasal mucosa are relevant and common today, and need more consideration and discussion. Given the complex etiopathogenetic mechanism, this pathology can lead to complications of the nasal cavity, such as: impaired mucociliary clearance and evacuation function of the nasal mucosa, as well as physiological, histological and morphological changes in atrophy of the nasal mucosa. Analyzing a large number of studies on pathogenetic aspects of atrophic changes of the nasal mucosa that may affect its development, namely: vascular disorders of microcirculation of nasal tissues, genetic predisposition, hypoxia of mucous tissues, climatic conditions, environmental conditions, labor, bad habits, exposure to drugs and the mental state of the patient that provoke the development of atrophic changes and lead to dysfunction of the ciliated epithelium due to changes in the vascular bed. Another important factor in the development of atrophy of the nasal mucosa is a violation of the chemical composition of nasal secretions. Diagnosis of these pathological conditions is complicated by a weak clinical picture, because it begins to bother the patient only in the critical stages of the disease, which significantly complicates the treatment of patients. If you do not pay attention to this problem, it can progress and provoke more serious complications up to perforation of the nasal remodeling, deformation of the outer nose or ozena, as well as cause disorders of other organs and systems or the psyche of patients. Therefore, it is necessary to develop a new more effective and safe method of treatment of patients with atrophic rhinitis, which will be more accessible and easier to use not only doctors in inpatient departments, but also outpatient ENT offices.

atrophic rhinitis, chronic rhinitis, anterior dry rhinitis, mucociliary clearance, microcirculatory tract, nasal cavity, nasal mucosa, obliterating endarteritis, perforation of the nasal partition, nosebleeds.

1. Shaila B, Somani, Akshay W, Sham S, Shivaji P. A study of Prevalence of primary and secondary atrophic rhinitis at tertiary health care centre. MedPulse International Journal of ENT. 2017;3(1):1–4
2. Serafim RA, do Espírito Santo RB, de Mello RAF, Collin SM, Deps PD. Case Report: Nasal Myiasis in an Elderly Patient with Atrophic Rhinitis and Facial Sequelae of Leprosy. The American Society of Tropical Medicine and Hygiene. 2020 Feb;102(2):448–450. DOI: 10.4269/ajtmh.19–0708.
3. Garsia GP, Bailie N, Martins DA. Atrophic rhinitis: a CFD study of air conditioning in the nasal cavity. J. Appl. Phisiol. 2007;103(3):1082–1092.
4. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82–111.
5. Bakshi SS. Atrophic Rhinitis. J Allergy Clin Immunol Pract. 2019;7(8):2850. DOI: 10.1016/j.jaip.2019.07.007.
6. Kim DH, Lee MH, Lee J, Song EA, Kim SW, Kim SW. Platelet-Rich Plasma Injection in Patients with Atrophic Rhinitis. ORL; journal for oto-rhino-laryngology and its related specialties. 2021;83(2):104–111. DOI: 10.1159/000513099.
7. Karpyshchenko SA, Lavrenova HV, Kulykova OA. Sovremennaia terapyia atrofycheskoho rinita. Lechebnoe delo. 2018;1:36–40. [in Russian].
8. Hurov AV, Yushkyna MA. Vozmozhnosty terapyy atrofycheskoho rynyta razlychnoi etyolohyy. Medytsynskyi sovet. 2018;20:100–106. [in Russian].
9. Bezshapochnii SB, Loburets VV, Loburets AV, Dzhirov OR, Podovzhnii OG. Osoblyvosti iryhatsii nosovoi porozhnyny pryhostrykh virusnykh rynosynusytakh. Svit medytsyny ta biolohii. 2020;3:7–12. [in Ukrainian].
10. Bezshapochnii SB, Loburets VV, Loburets AV. Optymizatsiia vedennia patsiientiv z khronichnym rynosynusytom, shcho zaznaly endoskopichnoho rynosynusokhirurhichnoho vtruchannia. Otorynolarynholohiia 2018;1:26–31. [in Ukrainian].
11. Bezshapochnii SB, Hasiuk YA, Loburets VV, Vakhnyna AB. Mekhanizmy mestnoi zashchity slyzystoi obolochki polosti nosa y okolonosovyh pazukh. Vestnik otorinolarinholohii. 2013;4:44–47. [in Russian].
12. Bezshapochnyi SB, Mirashova MH, Bakhkho A. Morfolohichni osoblyvosti slyzovoi porozhnyny nosa i navkolonosovykh pazukh z klinichnykh pozytsii. Tezy dop. Vseukr. nauk.-prakt. konf. likariv-interniv Aktualni pytannia klinichnoi medytsyny; 2019 Trav 23; Poltava. Poltava: UMSA; 2019. s. 12–13. [in Ukrainian].
13. Moore EJ, Kern EB. Atrophic rhinitis: a review of 242 cases. Am J Rhinol. 2001;15(6):355–361.
14. Dutt SN, Kameswaran M. The aetiology and management of atrophic rhinitis. J Laryngol Otol. 2005;119(11):843–852.
15. Liva GA, Karatzanis AD, Prokopakis EP. Review of Rhinitis: Classification, Types, Pathophysiology. J Clin Med. 2021:19;10(14):3183.
16. Martynets PA. Terapevtychni aspekty profesiino obumovlenoho obliteruiuchoho endarteriitu: etiolohiia, patohenez, diahnostyka, likuvannia, ekspertyza nepratsezdatnosti. Monohrafiia. Kryvyi Rih: Vydannia dim; 2006. 328 s. [in Ukrainian].
17. Bist SS, Bisht M, Purohit JP. Primary atrophic rhinitis: a clinical profile, microbiological and radiological study. ISRN Otolaryngol. 2012;2012:404075.
18. Ahapytova ME. Osobennosti strukturnikh izmenenyi slizistoi obolochki nosa u zhytelei promishlennoho horoda v norme i pry khronycheskom nespetsificheskom rinite. Ros. Otorynolarynholohyia. 2009;1:38–41. [in Russian].
19. deShazo RD, Stringer SP. Atrophic rhinosinusitis: progress toward explanation of an unsolved medical mystery. Curr Opin Allergy Clin Immunol. 2011;11(1):1–7.
20. Björk-Eriksson T. et al. Fewer problems with dry nasal mucous membranes following local use of sesame oil. Rhinology. 2000;38:200–203.
21. Mishra A, Kawatra R, Gola M. Interventions for atrophic rhinitis. Cochrane Database Syst Rev. 2012;15(2): CD 008280.
22. Passali D, Salerni L, Passali GC, Passali FM. Nasal decongestants in the treatment of chronic nasal obstruction: effi cacy and safely of use. Expert Opin Drag Saf. 2006;5(6):783–790.
23. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2):1–84.
24. Meltzer EO, Nathan R, Derebery J, Stang PE, Campbell UB, Yeh WS, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc. 2009;30(3):244–254.
25. Park MJ, Jang YJ. Successful management of primary atrophic rhinitis by turbinate reconstruction using autologous costal cartilage. Auris Nasus Larynx. 2018;45(3):613–616.
26. Ly TH, deShazo RD, Olivier J, Stringer SP, Daley W, Stodard CM. Diagnostic Criteria for Atrophic Rhinosinusitis. Am J Med. 2009;122(8):747–753.

«Bulletin of problems biology and medicine» Issue 2 Part 1 (164), 2022 year, 7-17 pages, index UDK 616.1/9:616.2

10.29254/2077-4214-2022-2-1-164-7-17